Exagen (XGN) Deferred Taxes (2020 - 2021)
Exagen (XGN) reported Deferred Taxes of $148000.0 for Q4 2021, up 1245.45% on a YoY basis from $11000.0 in Q4 2020, and up 1245.45% quarter-over-quarter from $11000.0 in Q4 2020.
Exagen (XGN) Deferred Taxes (2020 - 2021) Analysis & Trends
Exagen has reported Deferred Taxes for 2 years, with the latest figure at $148000.0 in Q4 2021.
- For the quarter ending Q4 2021, Deferred Taxes rose 1245.45% year-over-year to $148000.0; the trailing twelve-month figure through Dec 2021 stood at $148000.0 (up 239.62% YoY), and the FY2022 full-year result was -$306000.0, down 306.76% from the prior year.
- Deferred Taxes for Q4 2021 stood at $148000.0, up from $11000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $148000.0 in Q4 2021, with the low at -$117000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -1.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -258.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 13.89 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 32.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | - |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -38.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 3.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -1.99 Mn |
| 10 | Exagen | 102.82 Mn | 81.30 Mn | 10.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 148,000.00 |
| Dec 31, 2020 | 11,000.00 |
| Mar 31, 2020 | -117,000.00 |